diarrhea with retatrutide (“reta”) is an experimental weight-loss drug currently in Phase 3 clinical trials. It's a once-weekly injection similar to Ozempic and Mounjaro—but more powerful. The reason comes down to how it works Retatrutide Weight Loss Results:Trial Data

Injection Site Reactions Some people notice redness, itching, or slight swelling at the site where the medication was injected

Grading of the results The Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology was used to assess the quality of evidence for each outcome in the meta-analysis [24]

Depending on the location of the hemorrhage, patients may present with altered level of consciousness, headache, nausea, vomiting, dysarthria, ataxia, and motor or sensory deficits [8]

Weight loss of between 3 and 15% of body weight at initial diagnosis has been associated with remission of IIH [6, 7, 8]